Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (81-90 of 392) with videos related to

Pageof 40
Sort By:
Antimicrobial Agents and Chemotherapy|December 24, 2014
Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosisSeyedmojtaba Seyedmousavi, Johan W Mouton, Willem J G Melchers, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2013
Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosisSeyedmojtaba Seyedmousavi, Willem J G Melchers, Johan W Mouton, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2017
<i>In Vivo</i> Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive AspergillosisSeyedmojtaba Seyedmousavi, Johan W Mouton, Willem J G Melchers, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 25, 2012
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteriaJakko van Ingen, Martin J Boeree, Dick van Soolingen, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|January 1, 1997
[Blunt thoracic trauma with bronchial rupture]W Mouton, D Lardinois, H U Würsten, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Duration and clinical relevance of postantibiotic effect in relation to the dosing intervalJ G den Hollander, K Fuursted, H A Verbrugh, et al.
Infection|September 16, 2008
Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusionR A Bertels, B A Semmekrot, G P Gerrits, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141Johan W Mouton, Anne Schmitt-Hoffmann, Stuart Shapiro, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2005
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an updateJohan W Mouton, Michael N Dudley, Otto Cars, et al.
International Journal of Antimicrobial Agents|April 30, 2002
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugsJohan W Mouton, Michael N Dudley, Otto Cars, et al.
Pageof 40

Showing results (81-90 of 392) with videos related to

Sort By:
Pageof 40
Antimicrobial Agents and Chemotherapy|December 24, 2014
Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosisSeyedmojtaba Seyedmousavi, Johan W Mouton, Willem J G Melchers, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2013
Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosisSeyedmojtaba Seyedmousavi, Willem J G Melchers, Johan W Mouton, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2017
<i>In Vivo</i> Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive AspergillosisSeyedmojtaba Seyedmousavi, Johan W Mouton, Willem J G Melchers, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 25, 2012
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteriaJakko van Ingen, Martin J Boeree, Dick van Soolingen, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|January 1, 1997
[Blunt thoracic trauma with bronchial rupture]W Mouton, D Lardinois, H U Würsten, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Duration and clinical relevance of postantibiotic effect in relation to the dosing intervalJ G den Hollander, K Fuursted, H A Verbrugh, et al.
Infection|September 16, 2008
Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusionR A Bertels, B A Semmekrot, G P Gerrits, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141Johan W Mouton, Anne Schmitt-Hoffmann, Stuart Shapiro, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2005
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an updateJohan W Mouton, Michael N Dudley, Otto Cars, et al.
International Journal of Antimicrobial Agents|April 30, 2002
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugsJohan W Mouton, Michael N Dudley, Otto Cars, et al.
Pageof 40